Daniel Petrylak, MD, Yale School of Medicine
Advertisement
Articles by Daniel Petrylak, MD, Yale School of Medicine
Advertisement
Latest Updated Articles
Repeat Molecular Testing in Advanced Prostate CancerMarch 18th 2020
mCRPC: Advice for Treatment During COVID-19March 18th 2020
CARD Trial In Metastatic CRPCMarch 18th 2020
Sequencing Therapy in Castrate-Resistant Prostate CancerMarch 18th 2020
Counseling Patients With mCRPCMarch 18th 2020
Using Taxanes Frontline in Metastatic Prostate CancerMarch 18th 2020
Advertisement
Advertisement
Trending on OncLive
1
Vopimetostat Plus Daraxonrasib Yields 92% ORR in MTAP-Deleted, RAS-Mutant Pancreatic Cancer
2
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
3
GU Cancer Experts Highlight the Most Impactful and Discussion-Worthy Data Presented at ASCO 2026
4
May’s GI Monthly Rewind: A Landmark Approval in CCA, Expanded Access for Daraxonrasib, and More Key Pipeline Updates
5